Retraction Note to: Cell Death and Disease 9: 954 (2018) https://doi.org/10.1038/s41419-018-0978-y, published online 20 September 2018
The Editors have retracted this article. After publication, concerns were raised regarding overlap in the cell and tissue images presented in the figures, as well as the cell lines used in the study. Specifically:
-
There appears to be overlap in Fig. 2A and B between images representing different groups.
-
In Fig. 2C, the NC and pre-miR-665 0 h images appear to originate from the same sample.
-
There appears to be overlap in Fig. 5C and D between images representing different groups.
-
In Fig. 8E and F, the PTPRB images in the pre-miR-665 group appear to contain an overlapping area.
-
L02 and SMMC-7721 cell lines have been reported to be contaminated with HeLa and are therefore unsuitable for liver cancer research.
-
HepG2 cells have been reported to be unsuitable as a model of hepatocellular carcinoma.
Additionally, there is no patient consent statement in the article.
The authors have stated that the image errors occurred due to incorrect data storage.
The Editors therefore no longer have confidence in the presented data and the ethics of the study.
Yuanchang Hu has stated on behalf of all co-authors that they agree to this retraction.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hu, Y., Yang, C., Yang, S. et al. Retraction Note to: miR-665 promotes hepatocellular carcinoma cell migration, invasion, and proliferation by decreasing Hippo signaling through targeting PTPRB. Cell Death Dis 14, 95 (2023). https://doi.org/10.1038/s41419-023-05654-x
Published:
DOI: https://doi.org/10.1038/s41419-023-05654-x
